newsfilter.io

Malinka Walaliyadde

Showing 1–6 of 6 transcripts.

  1. a16z29 min

    a16z Podcast | Taking the Pulse on Bio

    Jorge Conde, Vijay Pande, Malinka Walaliyadde, Jeffrey Low, Hannah

    A16Z is shifting its bio-investment thesis from empirical science to engineered biology, prioritizing ventures where established biological mechanisms allow founders to apply AI and data-driven engineering to de-risk development. This approach targets sectors like diagnostic genomics and cell therapies, leveraging network effects and reusable platforms to transform unpredictable research into scalable, schedulable manufacturing processes. By favoring hybrid founders with expertise in both computer science and biology, the firm aims to accelerate innovation cycles and capture value in an era where technical execution supersedes novel biological discovery.

  2. a16z27 min

    a16z Podcast | The Taxonomy of Collective Knowledge

    Luis von Ahn, Jay Komarneni, Vijay Pande, Malinka Walaliyadde

    This presentation explores the evolution of data ontologies as structured frameworks that enable scalable coordination between human cognition and machine processing. It details specific implementations such as reCAPTCHA, Duolingo, and HumanDx, which leverage collective intelligence to solve complex tasks ranging from text recognition to medical diagnosis. By integrating weighted human expertise with algorithmic efficiency, the discussion outlines a future trajectory where these hybrid systems democratize access to high-level knowledge and healthcare without replacing individual professionals.

  3. a16z26 min

    a16z Podcast | The Rise of the Digital 'Pill'

    Sean Duffy, Vijay Pande, Malinka Walaliyadde, Hannah, Malinka Walaliate

    Digital health has evolved into a distinct third wave of therapeutics that treats behavioral and metabolic conditions through software-driven clinical interventions validated by rigorous randomized controlled trials. Despite past skepticism from medical authorities, industry leaders are overcoming adoption barriers by demonstrating superior efficacy in areas like diabetes management and shifting payment models toward value-based outcomes. The sector is increasingly integrating with existing healthcare infrastructure to act as a clinical collaborator rather than a replacement, with artificial intelligence poised to deepen this impact while addressing global provider shortages.

  4. a16z26 min

    a16z Podcast | When Will Genomics Live Up to the Hype?

    Carlos Araya, Jeff Kaditz, Gabe Otte, Malinka Walaliyadde, Hannah, Malinka Walaliate

    Panelists identify a critical disconnect between the static reference genome established by the Human Genome Project and the dynamic reality of somatic DNA errors, which Jeff Kaditz characterizes as an information corruption problem driving cancer. Experts propose leveraging artificial intelligence to integrate multi-omics data and longitudinal phenotypic records to transform probabilistic mutation calls into actionable preventative tools that mimic dental hygiene practices. Despite regulatory liability concerns and payer demands for immediate cost savings, the consensus points toward a consumer-paid "genomic thermometer" model that shifts healthcare from reactive treatment to proactive maintenance through scalable, affordable testing.

  5. a16z35 min

    a16z Podcast | Produce or Perish! (What We Eat)

    James Rogers, Malinka Walaliyadde, Sonal Chokshi

    Appeal Sciences leverages nanoscale material science to extract molecular isomers from plant biomass, creating an edible coating that preserves fresh produce by mimicking natural structural building blocks. This technology reduces global food waste, which currently reaches 50% in the US and up to 90% in developing nations, by extending shelf life to bypass the need for expensive cold chain infrastructure. Supported by a team of over 50 scientists, the company enables a future where crop selection prioritizes nutritional value and local soil suitability rather than transport durability, effectively decoupling food quality from geographic constraints.

  6. a16z30 min

    a16z Podcast | On the Genomics of Disease, From Science to Business

    Gabriel Otte, Vijay Pande, Malinka Walaliyadde, Sonal Chokshi

    Driven by the limitations of the Human Genome Project and the rapid decline in sequencing costs, the field has shifted from manual single-gene analysis to machine learning-enabled systems biology that identifies complex disease signals across the entire genetic code. Companies like Freenome now leverage this computational power to detect early-stage cancer signatures through non-invasive blood tests, potentially raising five-year survival rates from under 20% to over 80% before symptom onset. Despite these clinical breakthroughs, widespread adoption faces significant hurdles due to US insurance reimbursement models that prioritize short-term returns over long-term preventative value, prompting industry leaders to integrate vertically and explore data-rich applications in agriculture and mental health.